https://home.treasury.gov/system/files/136/PPP--Fact-Sheet.pdf
for borrowers
https://home.treasury.gov/system/files/136/PPP%20Lender%20Information%20Fact%20Sheet.pdf
for lenders
Keeping Workers Employed
- Small Business Administration – Coronavirus
Small Business Guidance
and Loan Resources
- Treasury Department – Resources
for the Paycheck Protection Program
- Treasury Department – FAQ:
Employee Retention Credit
Families and Workers
- Department of Labor – Resources for COVID-19 and the American Workplace
- Department of Labor – Temporary Rule
on Paid Leave under the Families First Coronavirus Response Act and Summary
- Department of Treasury – Social Security
Recipients Will Automatically Receive Economic Impact Payments
- IRS – Main Page for Coronavirus Tax
Relief Information
- IRS – Economic Impact Payments (Recovery
Rebates): What You Need
to Know
- IRS – Warning
about Scams on the Economic Impact Payments (Recovery Rebates)
- IRS – FAQ
on COVID-19 Related Tax Credits for Required Paid Sick Leave and Paid
Family Leave, under the Families First Coronavirus Response Act
- IRS – Notice on Paid Qualified
Sick Leave Wages and Family Leave Wages
- IRS – FAQ
on the Employee Retention Credit in the CARES Act
- IRS – Notice on Relief from
Penalty for Failure to Deposit Employment Taxes
- IRS – Notice on Relief for
Taxpayers Affected by Ongoing Coronavirus Disease 2019 Pandemic, Related
to Gift and Generation-Skipping Transfer Tax Filing and Payment Deadlines
- Department of Education – Coronavirus and
Forbearance Information
for Students, Borrowers, and Parents
Economic Stabilization for Distressed Industries
- Treasury Department – Guidelines
and Application Procedures for Payroll Support to Air Carriers and
Contractors
- Treasury Department – Procedures
and Minimum Requirements for Loans to Air Carriers and Eligible Businesses
and National Security Businesses
Health Care
- Federal Emergency Management Agency – Fact Sheet
on the Supply Chain Stabilization Task Force
- FDA – Coronavirus Treatment Acceleration
Program Resources
- FDA –Information
Regarding Drug Shortages of Hydroxychloroquine and Chloroquine
- Substance Abuse and Mental Health Services
Administration – Emergency Grants
to Address Mental and Substance Use Disorders during COVID-19
- Centers for Medicare and Medicaid Services Guidance
on Payment and Grace Period Flexibilities for Issuers Offering Coverage on
the Federally Facilitated Exchanges and State-Based Exchanges on the
Federal Platform
- CMS FAQ
on the Availability and Usage of Telehealth Services through Private
Health Insurance Coverage
- CMS FAQ
on Prescription Drugs and COVID-19 for Issuers Offering Health Insurance
Coverage in the Individual and Small Group Markets
- CMS Guidance Regarding Enhanced Medicaid
Funding for States – Federal Medical Assistance Percentage FAQ